Systemic lupus erythematosus - a state of hyperinterferonemia?

Area of Science:

• Immunology
• Virology
• Rheumatology

Background:

• Systemic lupus erythematosus (SLE) is a chronic autoimmune disease with diverse clinical manifestations.
• The role of cytokines, particularly interferons, in SLE pathogenesis is increasingly recognized.
• Clinical signs like alopecia, joint pain, fever, and leukopenia are characteristic of active SLE.

Purpose of the Study:

• To postulate the role of interferon in the clinical presentation of systemic lupus erythematosus.
• To explore the implications of interferon's role in SLE for therapeutic strategies and laboratory diagnostics.

Main Methods:

• Review of immunologic and microbiologic data.
• Analysis of recent clinical observations in SLE patients.

Main Results:

• Postulation that interferon is responsible for key clinical signs and symptoms in SLE.
• Identification of alopecia, joint manifestations, fever, and leukopenia as interferon-associated symptoms.
• Recognition of interferon's significant role in active SLE.

Conclusions:

• Therapeutic strategies for active SLE should aim to reduce interferon activity.
• Interferon levels may serve as a valuable laboratory marker for disease activity in SLE.